HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dose-dense paclitaxel for advanced ovarian cancer.

AuthorsYue-Can Zeng, Rong Wu, Zhao-Guo Xu, Feng Chi
JournalLancet (London, England) (Lancet) Vol. 375 Issue 9711 Pg. 280-1; author reply 281 (Jan 23 2010) ISSN: 1474-547X [Electronic] England
PMID20109950 (Publication Type: Comment, Letter)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • CA-125 Antigen
  • Carboplatin
  • Paclitaxel
Topics
  • Antineoplastic Agents, Phytogenic (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • CA-125 Antigen (analysis)
  • Carboplatin (administration & dosage)
  • Disease-Free Survival
  • Drug Administration Schedule
  • Female
  • Humans
  • Ovarian Neoplasms (drug therapy, mortality, pathology)
  • Paclitaxel (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: